Lymphoma-specific survival outcomes of patients with FL based in cumulative incidence and competing risk. Cumulative incidence plots of competing risk lymphoma-specific (A) PFS and (B) OS by investigator assessment for enrolled patients with FL. Main events included those due to lymphoma or study treatment complications. Events due to reasons other than lymphoma or study treatment complications were considered competing risks.